Background: A number of studies of genetic epidemiology have assessed the association of C-589T (also referred to as C-590T; rs number, 2243250) polymorphisms in the promoter region of interleukin-4 (IL-4) gene with asthma in different populations. However, the results are inconsistent and inconclusive. Objectives: We performed a meta-analysis of the association between C-589T polymorphisms of IL-4 and asthma with the following objectives: to estimate the magnitude of the gene effect and the possible mode of inheritance. Methods: A genetic model-free approach was used to perform a meta-analysis. Asthma (atopy status nondefined), nonatopic and atopic asthma subgroups were separately analyzed. Heterogeneity and publication bias were also explored. Results: Our meta-analysis summarized the evidence regarding the association between C-589T polymorphisms in the promoter region of IL-4 gene and asthma. When all asthma groups were pooled, a significant association of increased asthma risk and T allele was found. In subgroup analysis, our results indicated a significant association and a recessive genetic mode of C-589T polymorphisms of IL-4 with atopic asthma. The CC genotype was about 21 percent less likely to have atopic asthma than the genotype CT and TT. However, C-589T polymorphisms were not significantly associated with nonatopic asthma. Conclusions: This meta-analysis suggests there may be an important effect of single nucleotide polymorphisms (SNPs) in the promoter region of IL-4 gene on the pathogenesis of atopic asthma. This warrants further investigation in larger studies and meta-analysis.
Introduction
Asthma is one of the most common respiratory diseases caused by acute and chronic bronchial inflammation that results in variable airway obstruction. 1 As for etiology, asthma is a complex genetic disease resulted from interactions between multiple genes and environmental factors. 2 IL-4 gene has been mapped to chromosome 5q31 where asthma and atopy have also been linked. 3 A number of studies of genetic epidemiology have assessed the association of C-589T (also referred to as C-590T, rs number 2243250) SNPs in the promoter region of IL-4 with asthma in different populations. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] However, the results are inconsistent and inconclusive.
Population-based genetic epidemiology often seeks to identify relatively small effects against a complex etiological background. Because of this, most genetic association studies tend to be statistically underpowered. Meta-analysis allows using all the available published data to increase the statistical power and identify causative genes with reliability. In the meantime, there have been new developments in the methodology of meta-analysis of genetic studies. [21] [22] [23] A genetic model-free approach was suggested to the metaanalysis of genetic association studies. 22, 23 We therefore used the genetic model-free approach to perform a meta-analysis of the association between C-589T polymorphisms of IL-4 and asthma with the following objectives: to ascertain if there is an effect of these polymorphisms on asthma susceptibility, and if so to estimate the magnitude of that effect and the possible mode of inheritance.
Material and methods

Search strategy
Medline database (from January 1966 to November 2007) was comprehensively searched using the 'PubMed' search engine. Chinese Biomedical Literature database (CBM) was searched (from January 1980 to November 2007) for studies published in Chinese. The search strategy was the following.
1. Asthma (MeSH) 2. Interleukin-4 (MeSH) 3. Genotype* or allele* or mutation* or variant* polymorphism* (textword) 4. 1 and 2 and 3
Searching was performed in duplicate by two independent reviewers (Y.L. and J.H.). Results were limited to English language papers and Chinese language papers.
Inclusion criteria
Human studies, regardless of sample size, were included if they met the following criteria:
(1) IL-4 polymorphisms at C-589T or C-590T were determined. (2) Studies were case-control design (retrospective or nested case-control). The outcome was asthma (incident or prevalent), and there were at least two comparison groups, for example, asthma vs. control (nonasthma) groups. Participants could be of any age. The design based on family or sibling-pairs was excluded. (3) Each genotype frequency was reported, and there was sufficient information for extraction of data.
Data extraction
Data were extracted independently and in duplicate by two reviewers (Y.L. and J.H.) who used a standardized data extraction form. Genotypes authors, journals years of publication, demographics, selection/characteristics of cases and controls, and racial descent were extracted from each study. Any disagreement was resolved by discussion and consensus.
Quality score assessment
The quality of studies was also independently assessed by the two reviewers (Y.L. and J.H.) who used quality assessment scores of molecular association studies of asthma recommended by Thakkinstian et al. 23 These scores were based on both traditional epidemiologic considerations and genetic issues. 21 Total scores ranged from 0 (worst) to 15 (best). Any disagreement was adjudicated by a third author (H.X.). Low quality studies, quality score p4, were excluded.
Statistical analysis
First, all asthma groups were combined for meta-analysis. The C and T alleles of C-589T variants were compared. Separate analyses in dominant (genotype CC+CT vs. TT) and recessive (genotype CC vs. CT+TT) genetic models were also performed for the association with asthma.
Second, subgroups were analyzed based on asthma definition: asthma (atopy status nondefined); atopic asthma; and nonatopic asthma. Genetic association, magnitude and genetic model were tested by a genetic model-free approach as described by Thakkinstian et al. 22, 23 Briefly, the process consists of the following steps:
(1) Checking Hardy-Weinberg equilibrium (HWE): HWE was checked only in the control groups using chi-square goodness of fit. (2 Interleukin-4 polymorphisms and asthmaof less than 0.05 was considered statistically significant, except for tests of heterogeneity where a level of 0.10 was used.
Results
Medline and CBM database were comprehensively searched. The possible relevant full papers were retrieved. We identified 24 publications (including studies published in Chinese) that had evaluated the association of C-589T or C-590T polymorphisms with asthma. Ten studies were excluded for the following reasons: sibling-paired and family-based study design, 25, 26 no allele or genotyping frequency, [27] [28] [29] repeat publication, 30, 31 and low quality (quality scorep4). 9, 10, 16 Fourteen studies were judged to have met the inclusion criteria and provided complete data in the paper. [4] [5] [6] [7] [8] [11] [12] [13] [14] [15] [17] [18] [19] [20] Total sample sizes for asthma and control groups were 2476 and 2339, respectively. The characteristics of the study populations were extracted (Table 1) .
When all asthma groups were combined for meta-analysis, a statistically significant association of increased asthma risk and T allele, relative to the C allele (OR, 0.86; OR 95% CI, 0.78-0.94; p ¼ 0.002), was found ( Figure 1A) . The recessive genetic model (genotype CC vs. genotype CT+TT) demonstrated significant association of the CT+TT genotype with asthma (OR, 0.75; OR 95% CI, 0.64-0.89; p ¼ 0.001) ( Figure 1B) . However, no significant association was found in dominant genetic model (genotype CC+CT vs. genotype TT; OR, 0.89; OR 95% CI, 0.78-1.03; p ¼ 0.106).
We have estimated the number of subjects needed to detect significant ORs for logistic regression analysis (Figure 2 ). For an assumed the average frequency of subjects carrying at least one T allele (genotype ¼ CT or TT) of 0.32 (estimated from the reports that met the inclusion criteria) in the control population and a significance level of 0.05 with a power of 0.8, the number of subjects per group is about 414 (unmatched case-control, 1:1) to detect significant OR of 1.5. A bigger sample size is needed to detect an OR of less than 1.5 with a power of 0.8 and a significance level of 0.05 for association of asthma and IL-4 C-589T genotype CT or TT.
Subgroups were analyzed based on asthma definition: asthma (atopy status nondefined); atopic asthma; and nonatopic asthma. Genotype frequencies of the C-589T polymorphism in different subgroups were provided in Table 2 . A genetic model-free approach was used to evaluate the genetic models of subgroups.
As for atopic asthma subgroup, all studies, except one, 20 in HWE were included in pooling. Results indicated heterogeneity for OR1 and OR3 but not for OR2 (Table 3) . Logistic regression with the random-effect model was used to assess the overall gene effect. The overall gene effect was significant [LR test, w 2 ¼ 7.10, p ¼ 0.03]. The estimated OR1, OR2 and OR3 were 0.75, 1.00 and 0.76, respectively (Table 3) . These estimates suggest a recessive genetic model, and therefore TT and CT were combined and compared with CC. The pooled odds ratio was 0.79 (95% CI: 0.64, 0.96, p ¼ 0.02) (Figure 3 and Table 3 ).
As for nonatopic asthma subgroup, the six studies observing HWE were pooled.
10,15-17,19,24 There was no heterogeneity for OR1, OR2 or OR3 (Table 3) . Logistic regression with the fixed-effect model was used to assess the overall gene effect, and the result was not significance level (w 2 ¼ 0.07, p ¼ 0.97). The estimated OR1, OR2 and OR3 were 0.97, 1.01 and 0.96, respectively (Table 3) . These results suggest a recessive genetic model for nonatopic asthma. However, the pooled odds ratio was not significant (OR, 0.96; p ¼ 0.80) in recessive model ( Figure 3 and Table 3 ).
Discussion
Our meta-analysis summarized the evidence to date regarding the association between C-589T polymorphisms and asthma, representing a pooled total of 2476 cases and 2339 controls, respectively. When all asthma groups were pooled, a significant association of increased asthma risk and T allele was found. In subgroup analysis, our results indicated a significant association and a recessive genetic mode of C-589T polymorphisms of IL-4 with atopic asthma. The CC genotype was about 21 percent less likely to have atopic asthma than the genotype CT and TT. Our results also suggested C-589T polymorphisms were not significantly associated with nonatopic asthma.
For IL-4 C-589T, located in the promoter region of the IL-4 gene, it was shown T allele is associated with increasing of the binding of a transcription factor. 32, 33 Therefore, it can be hypothesized that this single nucleotide polymorphism may lead to an overexpression of the IL-4 gene and thus upregulate IL-4-dependent immunological reaction. In previous study, 34, 35 IL-4 was found to play a major role in allergic disease, as it mediates Ig isotype switching from IgM to IgE. Therefore, IL-4 is thought to be a direct participant in the generation of high serum levels of IgE that are observed in atopic individuals. However, the exact mechanisms how Figure 2 Estimation of the number of subjects needed to detect significant ORs for logistic regression analysis. For an assumed genotype (CT+TT) frequency of 0.3 in the control population, presented are estimations of power vs. number of subjects per group needed to detect the indicated ORs of a causal allele at a significance level of 0.05, assuming no genotyping errors, missing data, or population heterogeneity.
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these IL-4 polymorphisms affect atopic asthma risk at the molecular level is still speculative. Further studies with large population should be done to demonstrate the true effect of C-589T polymorphisms on asthma.
Attia et al. 21 found that meta-analysis of populationbased molecular association studies have become increasingly common over the last 10 years, but little attention has been paid to methodology, particularly with regard to two issues: testing HWE, and pooling results in a manner that reflects a biological model of gene effect. We used the model-free approach to pool population-based molecular association studies. This approach does not assume a priori genetic model and avoids the problem of multiple comparisons. 22 In addition, we calculated Hardy-Weinberg equilibrium for all publications. The studies not in HWE were excluded in pooling results.
There are several limitations that should be considered when interpreting our results. Firstly, asthma itself is heterogeneous and as such the divergent inclusion criteria among patient groups might also lead to difficulties in pooling the various studies. Secondly, the asthma phenotype was often not fully specified in some studies, and details of asthma diagnoses were often scanty. Thirdly, controls should also be tested to screen out asthma and fully define the topic status in the future studies.
Publication bias was not a major problem for this metaanalysis study because most of the published studies reported no significant effects of the C-589T polymorphisms on asthma risk. Significance tests also did not suggest the presence of publication bias for most studies (p ¼ 0.72). Recently, Lau et al. 36 doubted the widely used method of funnel plot does not accurately predict publication bias. A true standard measure of publication bias would require prospective registries of studies with detailed knowledge of which studies have been published and which are unpublished. Given that efforts for study registration have only recently started, this evaluation is currently difficult.
To conclude, this may be the first systematic and comprehensive meta-analysis of C-589T polymorphisms in IL-4 and asthma. A significant recessive protective mode was found in IL-4 C-589T polymorphisms with atopic asthma. These results suggest the important effect of SNPs in the promoter region of IL-4 gene on the pathogenesis of asthma. This warrants further investigation in larger studies and meta-analysis.
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